Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cipla
US Army
Fuji
Federal Trade Commission
Chubb
Fish and Richardson
Harvard Business School
Dow
Novartis

Generated: October 21, 2017

DrugPatentWatch Database Preview

Sun Pharm Inds Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?

SUN PHARM INDS LTD has one hundred and sixteen approved drugs.

There are eight US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.

There are thirty-one patent family members on SUN PHARM INDS LTD drugs in nineteen countries and one hundred and thirty supplementary protection certificates in thirteen countries.

Summary for Applicant: Sun Pharm Inds Ltd

International Patents:31
US Patents:8
Tradenames:89
Ingredients:86
NDAs:116
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
SOTRET
isotretinoin
CAPSULE;ORAL076041-001Dec 24, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL204293-001Jun 5, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
FENOFIBRATE
fenofibrate
TABLET;ORAL076635-003Oct 31, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
XIMINO
minocycline hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL201922-003Jul 11, 2012RXNoNo► Subscribe► Subscribe ► Subscribe
Sun Pharm Inds Ltd
CETIRIZINE HYDROCHLORIDE HIVES
cetirizine hydrochloride
TABLET;ORAL077498-004Dec 27, 2007OTCNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
XIMINO
minocycline hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL201922-003Jul 11, 2012RXNoNo► Subscribe► Subscribe ► Subscribe
Sun Pharm Inds Ltd
AMLODIPINE BESYLATE
amlodipine besylate
TABLET;ORAL077974-001Jul 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
OXCARBAZEPINE
oxcarbazepine
SUSPENSION;ORAL078734-001Jun 26, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
SUMATRIPTAN SUCCINATE
sumatriptan succinate
TABLET;ORAL076572-001Feb 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL077498-001Dec 27, 2007OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Sun Pharm Inds Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Ltd
ULTRAVATE
halobetasol propionate
CREAM;TOPICAL019967-001Dec 27, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Sun Pharm Inds Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,559,187 Liquid formulation of metformin► Subscribe
9,192,615Method for the treatment of acne and certain dosage forms thereof► Subscribe
8,722,650Extended-release minocycline dosage forms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Sun Pharm Inds Ltd Drugs

Country Document Number Estimated Expiration
Canada2416767► Subscribe
Brazil0113102► Subscribe
China101208097► Subscribe
World Intellectual Property Organization (WIPO)0211716► Subscribe
South Africa200802064► Subscribe
Japan2008543936► Subscribe
CroatiaP20030161► Subscribe
Yugoslavia8803► Subscribe
Japan2013213047► Subscribe
Norway20080444► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1730131/02Switzerland► SubscribePRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015
12/018Ireland► SubscribePRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AMLODIPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/11/730/001-060 20111122; FIRST REGISTRATION NO/DATE: SWITZERLAND 6167801-6167805 20110705
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
00524Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN SAXAGLIPTINE EN METFORMINE, DESGEWENST IN DE VORM VAN FARMACEUTISCH AANVAARDBARE AFGELEIDEN DAARVAN; NAT. REGISTRATION NO/DATE: EU/1/11/731/001-012 20111124; FIRST REGISTRATION:
00714Netherlands► SubscribePRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718
C/GB95/028United Kingdom► SubscribePRODUCT NAME: TOPIRAMATE; REGISTERED: UK 0242/0301 19950718
C/GB12/058United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
2013 00001Denmark► SubscribePRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION ENANTIOMERER OG SALTE DERAF - SAERLIGT LINAGLIPTIN - I KOMBINATION MED METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/12/780/001-028 20120720
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Argus Health
Colorcon
Johnson and Johnson
QuintilesIMS
Mallinckrodt
Chinese Patent Office
Farmers Insurance
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot